FDA
-
-
-
-
-
-
-
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company Growth
-
-
-
-
-
-
-
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
-
-
-
-
-
-
-
Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting
-
-
-
-
-
-
-
Predictive Oncology Inc. (POAI) Subsidiaries Soluble Biotech Inc. and TumorGenesis Inc. are both constructing new GMP labs
-
-
-
-
-
-
-
Predictive Oncology Announces $21.34 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
-
-
-
-
-
-
Predictive Oncology Inc. (POAI) Announces Newest Board Member
-
-
-
-
-
-
-
Predictive Oncology Reports Year End 2020 Financial Results, Provides Business Update
-
251,410 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All